公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
公司地址 1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
電話號碼 +353 17728000
傳真號碼 --
公司網頁 https://www.alkermes.com
員工數量 2050
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. David Joseph Gaffin Executive Vice President, Chief Legal Officer, Secretary and Chief Compliance Officer 美元 684.50K 06/04/2026
Dr. Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 美元 764.84K 06/04/2026
Mr. Joshua Reed Senior Vice President and Chief Financial Officer 美元 181.98K 06/04/2026
Mr. Christian Todd Nichols Senior Vice President and Chief Commercial Officer 美元 614.87K 06/04/2026
Mr. Blair C. Jackson Executive Vice President, Chief Executive Officer and Chief Operating Officer 美元 736.45K 25/02/2026
Mr. Samuel J. Parisi Interim Principal Accounting Officer; Vice President, Finance of Alkermes, Inc. -- 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Brian P. Mckeon Independent Director 06/04/2026
Dr. Cato T. Laurencin,M.D.,PhD Independent Director 06/04/2026
Ms. Nancy S. Lurker Independent Director 06/04/2026
Mr. Richard F. Pops Chairman of the Board 25/02/2026
Mr. Frank Anders Wilson Lead Independent Director 06/04/2026
Mr. Shane M. Cooke Independent Director; Chairman of the Board of Alkermes Pharma Ireland Limited 06/04/2026
Ms. Anne Michelle Clem Whitaker Independent Director 16/09/2026
Dr. Nancy L. Snyderman, F.A.C.S.,M.D. Independent Director 06/04/2026
Dr. Richard Brian Gaynor, M.D. Independent Director 06/04/2026
Dr. Christopher I. Wright, M.D.,PhD Independent Director 06/04/2026
 
所屬ETF (更新日期: 14/11/2026 03:59)
代號 名稱 佔比% ▼ 持有日期
GUSAGoldman Sachs MarketBeta US 1000 Eq ETF0.003%30/10/2026
UWMProShares Ultra Russell20000.003%30/10/2026
GRXGabelli Health & Wellness0.003%30/06/2026
RUSCRussell Inv U.S. Small Cap Equity ETF0.003%31/10/2026
TDNAT. Rowe Price Biotech ETF0.003%31/10/2026
PDNInvesco RAFI Developed Mkts ex-US S-METF0.002%30/10/2026
MMSCFirst Trust Multi-Manager Sm Cp Opps ETF0.002%29/10/2026
CVLCCalvert US Large-Cp Cor Rspnb ETF0.002%30/10/2026
FTKIFirst Trust Small Cp BuyWrt Inc ETF0.002%29/10/2026
AVTMAvantis Total Equity Markets ETF0.002%30/10/2026
SPXXNuveen S&P 500 Dynamic Overwrite0.001%30/09/2026
FNDBSchwab Fundamental U.S. Broad Market ETF0.001%31/10/2026
MFUSPIMCO RAFI Dyn Multi-Factor US Eq ETF0.001%30/10/2026
SAAProShares Ultra SmallCap6000.001%30/10/2026
BMEDiShares Health Innovation Active ETF0.001%30/10/2026
CVMCCalvert US Mid-Cp Cor Rspnb ETF0.001%30/10/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.001%30/10/2026
AVSUAvantis Responsible US Equity ETF0.001%30/10/2026
ESSCEventide Small Cap ETF0.001%30/10/2026
TMEDT. Rowe Price Health Care ETF0.001%31/10/2026
  1    2    3    4    5   6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.